Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Natus Medical Incorporated (NTUS : NSDQ)
 
 • Company Description   
Natus Medical Incorporated is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories.

Number of Employees: 1,400

 
 • Price / Volume Information   
Yesterday's Closing Price: $32.57 Daily Weekly Monthly
20 Day Moving Average: 1,012,163 shares
Shares Outstanding: 34.58 (millions)
Market Capitalization: $1,126.31 (millions)
Beta: 0.23
52 Week High: $33.93
52 Week Low: $21.31
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 25.03% 36.49%
12 Week 41.24% 52.65%
Year To Date 37.25% 62.57%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3150 PLEASANT VIEW ROAD
-
MIDDLETON,WI 53562
USA		 ph: 608-829-8500
fax: 650-802-0401		 investorrelations@natus.com http://www.natus.com
 
 • General Corporate Information   
Officers
Thomas J. Sullivan - Chief Executive Officer and President
Joshua H. Levine - Chairperson
B. Drew Davies - Chief Financial Officer and Executive Vice Preside
Ilan Daskal - Director
Eric J. Guerin - Director

Peer Information
Natus Medical Incorporated (ABMD)
Natus Medical Incorporated (DMDS)
Natus Medical Incorporated (CPWY.)
Natus Medical Incorporated (EQUR)
Natus Medical Incorporated (ECIA)
Natus Medical Incorporated (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 639050103
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 34.58
Most Recent Split Date: (:1)
Beta: 0.23
Market Capitalization: $1,126.31 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.32 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $1.44 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 22.62
Trailing 12 Months: 25.85
PEG Ratio: -
Price Ratios
Price/Book: 2.61
Price/Cash Flow: 16.15
Price / Sales: 2.35
EPS Growth
vs. Year Ago Period: 37.50%
vs. Previous Quarter: -53.19%
Sales Growth
vs. Year Ago Period: 4.23%
vs. Previous Quarter: -6.89%
ROE
03/31/22 - 10.15
12/31/21 - 9.75
09/30/21 - 9.07
ROA
03/31/22 - 7.65
12/31/21 - 7.21
09/30/21 - 6.55
Current Ratio
03/31/22 - 2.54
12/31/21 - 2.42
09/30/21 - 2.52
Quick Ratio
03/31/22 - 1.90
12/31/21 - 1.83
09/30/21 - 1.83
Operating Margin
03/31/22 - 9.00
12/31/21 - 8.61
09/30/21 - 8.12
Net Margin
03/31/22 - 2.65
12/31/21 - 2.78
09/30/21 - 3.59
Pre-Tax Margin
03/31/22 - 4.15
12/31/21 - 4.09
09/30/21 - 4.76
Book Value
03/31/22 - 12.46
12/31/21 - 12.44
09/30/21 - 12.37
Inventory Turnover
03/31/22 - 2.94
12/31/21 - 2.88
09/30/21 - 2.77
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©